The effect of nitric oxide synthase inhibition with and without inhibition of prostaglandins on blood flow in different human skeletal muscles

dc.contributor.authorlkka Heinonen
dc.contributor.authorBengt Saltin
dc.contributor.authorYlva Hellsten
dc.contributor.authorKari K. Kalliokoski
dc.contributor.organizationfi=PET-keskus|en=Turku PET Centre|
dc.contributor.organizationfi=kliininen laitos|en=Department of Clinical Medicine|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organization-code1.2.246.10.2458963.20.14646305228
dc.contributor.organization-code1.2.246.10.2458963.20.61334543354
dc.converis.publication-id28636395
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/28636395
dc.date.accessioned2022-10-28T14:26:07Z
dc.date.available2022-10-28T14:26:07Z
dc.description.abstractPurpose Animal studies suggest that the inhibition of nitric oxide synthase (NOS) affects blood flow differently in different skeletal muscles according to their muscle fibre type composition (oxidative vs glycolytic). Quadriceps femoris (QF) muscle consists of four different muscle parts: vastus intermedius (VI), rectus femoris (RF), vastus medialis (VM), and vastus lateralis (VL) of which VI is located deep within the muscle group and is generally regarded to consist mostly of oxidative muscle fibres.Methods We studied the effect of NOS inhibition on blood flow in these four different muscles by positron emission tomography in eight young healthy men at rest and during one-leg dynamic exercise, with and without combined blockade with prostaglandins.Results At rest blood flow in the VI (2.6 +/- 1.1 ml/100 g/min) was significantly higher than in VL (1.9 +/- 0.6 ml/100 g/min, p = 0.015) and RF (1.7 +/- 0.6 ml/100 g/min, p = 0.0015), but comparable to VM (2.4 +/- 1.1 ml/100 g/min). NOS inhibition alone or with prostaglandins reduced blood flow by almost 50% (p < 0.001), but decrements were similar in all four muscles (drug x muscle interaction, p = 0.43). During exercise blood flow was also the highest in VI (45.4 +/- 5.5 ml/100 g/min) and higher compared to VL (35.0 +/- 5.5 ml/100 g/min), RF (38.4 +/- 7.4 ml/100 g/min), and VM (36.2 +/- 6.8 ml/100 g/min). NOS inhibition alone did not reduce exercise hyperemia (p = 0.51), but combined NOS and prostaglandin inhibition reduced blood flow during exercise (p = 0.002), similarly in all muscles (drug x muscle interaction, p = 0.99).Conclusion NOS inhibition, with or without prostaglandins inhibition, affects blood flow similarly in different human QF muscles both at rest and during low-to-moderate intensity exercise.
dc.format.pagerange1175
dc.format.pagerange1180
dc.identifier.jour-issn1439-6319
dc.identifier.olddbid188250
dc.identifier.oldhandle10024/171344
dc.identifier.urihttps://www.utupub.fi/handle/11111/51500
dc.identifier.urlhttps://link.springer.com/article/10.1007/s00421-017-3604-2
dc.identifier.urnURN:NBN:fi-fe2021042718054
dc.language.isoen
dc.okm.affiliatedauthorHeinonen, Ilkka
dc.okm.affiliatedauthorKalliokoski, Kari
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.discipline1184 Genetics, developmental biology, physiologyen_GB
dc.okm.discipline315 Sport and fitness sciencesen_GB
dc.okm.discipline1184 Genetiikka, kehitysbiologia, fysiologiafi_FI
dc.okm.discipline315 Liikuntatiedefi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherSPRINGER
dc.publisher.countryGermanyen_GB
dc.publisher.countrySaksafi_FI
dc.publisher.country-codeDE
dc.relation.doi10.1007/s00421-017-3604-2
dc.relation.ispartofjournalEuropean Journal of Applied Physiology
dc.relation.issue6
dc.relation.volume117
dc.source.identifierhttps://www.utupub.fi/handle/10024/171344
dc.titleThe effect of nitric oxide synthase inhibition with and without inhibition of prostaglandins on blood flow in different human skeletal muscles
dc.year.issued2017

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
10.1007_s00421-017-3604-2.pdf
Size:
866.41 KB
Format:
Adobe Portable Document Format
Description:
Publisher's PDF